Nabi-HB

hepatitis B immune globulin · Biotest Pharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nabi-HB, covering 2016-01-18 to 2016-01-18. Get the full timeline:

Most recent: Clinical Trial Update: Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation [Phase 3]